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ABSTRACT 
Tammy Ruozhang Xu: The Effect of Grid Resolution on the Global Mortality Burden of 
Fine Particulate Matter and Ozone 
(Under the direction of J. Jason West) 
 
Coarse resolution models are sometimes needed to simulate air pollution-related deaths 
in policy scenarios, but do not resolve human exposure well.  We quantify the effect of grid 
resolution on global premature mortality estimates attributable to ozone (O3) and fine particulate 
matter (PM2.5), by comparing model simulations at fine (0.125°x0.125°) and coarse resolution 
(2.5°x 2°). 
We estimate a global burden of 3.8 (95% CI: 2.3, 5.3) million deaths per year for PM2.5 
and 0.68 (0.41, 0.92) million deaths for O3 at fine resolution.  Globally we estimate a total bias of 
-15.8% (-21.1%, -12.1%) for PM2.5 and -9.0% (-9.4%, -8.6%) for O3 at the coarser resolution. By 
upscaling the fine resolution to 2.5°x2° by simple averaging, we find that most of the bias at 
coarse resolution results from changes in model chemistry rather than the spatial alignment of 
population and concentrations. The bias at coarse resolution varies substantially among world 
regions. 
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CHAPTER 1: INTRODUCTION 
Air pollution is identified as a huge public health concern. It’s estimated that around 92% 
of the world’s population are exposed to air quality levels that exceed WHO limits (Shaddick et 
al., 2018).The Global Burden of Disease study ranks ambient fine particulate matter (PM2.5) as 
the 10th leading risk factor for mortality globally, and the most important environmental risk 
factor, accounting for 2.9 (95% CI: 2.5, 3.4) million annual premature deaths (GBD 2017 Risk 
Factor Collaborators, 2018). Ozone (O3) is associated with 0.5 (95% CI: 0.2,0.8) million annual 
premature deaths (GBD 2017 Risk Factor Collaborators, 2018). Associations between PM2.5 
and both short-term and long-term adverse health effects including cardiovascular diseases, 
respiratory diseases, and premature mortality have been well established by epidemiology 
studies (Schwartz et al.1996, Pope and Dockery, 2006; Pope et al., 2009, 2011; Burnett et 
al.,2014). O3 has also been linked to premature mortality from respiratory diseases and COPD 
(Ito et al., 2005; Zanobetti and Schwartz, 2011; Jerret et al., 2009; Turner et al., 2016). 
Accurate exposure estimates for air pollution are crucial for both epidemiology studies 
and health impact studies. Health impact assessments often use air quality models to simulate 
exposure concentrations for more complete spatial and temporal data, and because of the 
ability of models to analyze different factors such as changes in emissions for hypothetical 
scenarios (Liang et al., 2018; Silva et al, 2017). Global atmospheric models run at resolutions of 
about 100-400 km are often used in health impact assessments due to limitations of 
computational speed (Anenberg et al., 2010). 
Coarse resolutions can lead to biased health impact estimates due to the effect of grid 
resolution on “exposure”, defined as the spatial misalignment of population data and air pollution 
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data, especially in highly populated urban areas (Punger and West, 2013). In particular, air 
pollution is often highest where population density is high, such as cities.  As a result, coarse 
resolutions fail to capture gradients of high exposures to concentrations, and may assign 
concentrations to large urban populations that differ from actual. In addition, both modeled O3   
and PM concentrations have been shown to be sensitive to the effect of grid resolution on 
model “chemistry” because spatial averaging of emissions can influence chemical production 
and hence dilute the concentration gradients (Schaap et al., 2015; Tie et al., 2010; De Meij et 
al., 2007; Fountoukis et al., 2013; Wild and Prather, 2006).  
Several studies have investigated the effect of resolution on health impacts, as 
summarized in Table 1. Some of the studies investigated resolutions used by regional 
atmospheric models (Thompson et al., 2014; Jiang and Yoo, 2018; Korhonen et al., 2019) while 
some studied global model resolutions (Punger and West, 2013; Li et al., 2016; Fenech et al., 
2018). Several studies found larger bias around highly populated areas (Punger and West, 
2013; Thompson et al., 2014; Korhonen et al., 2019).  For PM2.5, previous research has 
inconsistent results. Some studies reported underestimation at coarse resolutions (Punger and 
West, 2013; Li et al., 2016), some reported overestimation (Jiang and Yoo, 2018) and some 
found both negative and positive bias depending on subregions within the study domain 
(Thompson et al., 2014; Fenech et al., 2018). For O3, previous research agrees that coarse 
resolutions overestimate health impacts at regional and national scales.  
Punger and West (2013) and Korhonen et al. (2019) used an artificial method to scale 
the fine resolution to coarser ones to evaluate the effect of resolution on “exposure” only, 
neglecting the effect on model “chemistry”. Other studies ran the air quality model at different 
resolutions and hence were able to study the total effect of grid resolution on both model 
“chemistry” and “exposure” (Thompson et al., 2014; Li et al., 2016; Fenech et al., 2018; Jiang 
and Yoo, 2018). However, these studies are limited in the study domain. In addition, the 
resolutions that some studies evaluated are used for regional and local models only and do not 
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give much insight into the biases when using coarser global models. Thompson et al. (2014) 
and Jiang and Yoo (2018) studied subregions within the eastern and northeastern USA 
respectively, Punger and West (2013) studied the USA, Korhonen et al. (2019) Finland, and 
Fenech et al. (2018) Europe. Li et al. (2016) used a global atmospheric model but only focused 
on the USA. No studies have investigated the effect of resolution globally, addressing whether 
the biases from coarse resolution differ among world regions.  
We aim to understand the effects of grid resolution on estimates of premature mortality 
from exposure to both PM2.5 and O3 on the global scale and in different regions of the world.  We 
use the output from a simulation of global atmospheric chemistry from the NASA Goddard Earth 
Observing System Model version 5 Earth system model (GEOS-5 ESM) with GEOS-chem 
chemistry (G5NR-chem) at a fine horizontal resolution of 0.125° x 0.125° and a coarse 
resolution of 2.5° x 2°.  To our knowledge this is the finest resolution to date for a full year global 
atmospheric chemistry model simulation. By estimating mortality using concentrations at both 
modeled resolutions, we evaluate the total effect of grid resolution on estimates of premature 
mortality.  Further, by artificially upscaling resolution following Punger and West (2013), we 
estimate the contributions to the overall bias at coarse resolution from model “chemistry” vs. 
“exposure” both globally and in each world region.  
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Table 1. Previous research on the effect of grid resolution on health impact assessments 
Pollutant Study Domain 
Sources of bias 
studied 
Resolutions 
Compared  
(coarse vs. fine) 
Bias on Estimated Mortality at Coarse 
Resolutions 
PM2.5 
Punger and 
West (2013) 
USA Exposure 
>250 km vs. 12 
km 
Underestimates by -30 to - 40 % 
Li et al.  
(2016) 
Used a global 
atmospheric 
model but only 
focused on the 
USA 
Exposure and 
Chemistry 
2×2.5° vs. 
0.5×0.66° 
Underestimates by -8% 
Fenech et al.  
(2018) 
Europe 
Exposure and 
Chemistry 
1.875°× 1.25° 
vs. 0.44° × 0.44° 
Up to ± 5% of bias across Europe, with 
variations in seasons and regions 
Korhonen et al. 
(2019) 
Finland Exposure 50 km vs. 1 km 
Underestimates by -14% when using a 
log-linear relationship and by -90% using 
integrated exposure-response model 
(IER) 
Thompson et al. 
(2014) 
Subregions within 
the eastern USA 
Exposure and 
Chemistry 
36 km vs. 4 km 
and 12 km 
Agree to within ±10% among regions 
Jiang and Yoo  
(2018) 
New York State 
Exposure and 
Chemistry 
12 km vs. 4 km 
Overestimates by 15.3% but within the 
uncertainty range for the 4-km estimates 
O3 
Punger and 
West (2013) 
USA Exposure 
> 96 km vs 12 
km 
Overestimates by less than 6% 
Thompson et al. 
(2014) 
Subregions within 
the eastern USA 
Exposure and 
Chemistry 
36 km vs. 4 km 
and 12 km 
Overestimates by 200% in urban areas 
and by 8% in rural areas 
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CHAPTER 2: METHODOLOGY 
2.1: Experimental Design 
We conduct a health impact assessment to estimate the annual global mortality burden 
of PM2.5 and O3, first using atmospheric model output at the fine resolution, and then repeating 
the assessment for the coarse resolution model output to evaluate the bias resulting from the 
difference in resolution, globally and in each world region. The bias obtained by comparing the 
two modeled resolutions will reflect the total effect of grid resolution on premature mortality 
estimates, which consists of both the effect on “exposure” and model “chemistry”. Following the 
method of Punger and West (2013), we then upscale the modeled concentrations at fine 
resolution to the coarse resolution, without running the atmospheric model again, and repeat the 
assessment of mortality. Comparing estimates using the upscaled resolution and the fine 
resolution will only capture the effect on “exposure”, which allows us to then estimate the 
contributions to the overall bias at coarse resolution from model “chemistry” vs. “exposure” 
globally and in each world region.   
2.2: Modeled PM2.5 and O3 Concentrations 
PM2.5 and O3 concentrations are outputs from a one-year (July 2013 to June 2014) 
simulation of global atmospheric chemistry from the NASA Goddard Earth Observing System 
Model version 5 Earth system model (GEOS-5 ESM) with GEOS-Chem as the chemical module 
(G5NR-chem) (Hu et al., 2018). The model is run at a fine horizontal resolution of 0.125° 
longitude by 0.125° latitude (~13.8 x 13.8 km2 at the equator, with decreasing grid sizes when 
moving towards the poles), an unprecedented fine resolution for a global atmospheric model.  
The model was also run with the same inputs but at a coarse horizontal resolution of 2.5° 
longitude by 2° latitude (~276x 221 km2 at the equator), both with 72 vertical levels (Hu et al., 
2017, 2018). The two runs differ mainly in resolution, with other minor differences in transport 
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modules, the distribution of natural sources computed online, and meteorological data needed 
to run at the finer resolution (Hu et al., 2018). 
For O3, we use the exposure metric for long-term ozone pollution defined by Turner et al. 
(2016), the 6-month ozone season average of the daily 8-hr maximum ozone concentrations, in 
ppb, to be consistent with GBD 2017. To account for the variability in the seasonal pattern of O3 
across different world regions, which would affect when high O3 occurs in a year, we find the 
consecutive 6-month period with the highest average of the daily 8-hr maximum O3 
concentrations (6mDM8) for each grid cell, similar to the methods used in previous global 
studies (Silva et al., 2016, 2017). 
We use annual average as the exposure metric for long-term PM2.5 concentrations, 
following the GBD 2017 study (GBD 2017 Risk Factor Collaborators, 2018), estimated as a sum 
of modeled species, following the formula developed for this model: 1.33 (NIT + 132/96*SO4) + 
BCPI + BCPO + 2.1 (OCPO + 1.16 OCPI) + DST1 + 0.38 DST2 + 1.86 SALA. 
PM2.5 and O3 concentrations at 0.125° x 0.125° are upscaled to 2.5° x 2° by simple 
averaging of all 0.125° x 0.125° resolution grid cells within each 2.5° x 2° cell.  We then repeat 
the health impact assessment in order to control for the effect of model resolution on chemistry 
on the mortality estimates, and only evaluate the effect of model resolutions on exposure, 
characterized by the alignment of population and pollutant concentrations. 
2.3: Health Impact Assessment  
Using GBD 2017’s methods, we estimate the cause-specific premature mortality burden 
attributable to exposure to ambient air pollution (∆𝑀𝑜𝑟𝑡) in each grid cell globally using 
equations 1 and 2: 
∆𝑀𝑜𝑟𝑡 = 𝑦0 ∗ 𝐴𝐹 ∗ 𝑃𝑜𝑝 [1] 
where  ∆𝑀𝑜𝑟𝑡 is the change in mortality attributable to a change in exposure, 𝑦0 is the baseline 
mortality rate for each cause among the exposed population, 𝑃𝑜𝑝 is the exposed population, 
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and  𝐴𝐹 is the attributable fraction for each cause, defined as the contribution of a risk factor to 
a disease or death burden (WHO, 2014; Benichou, 2001). AF is calculated as: 
𝐴𝐹 = (𝑅𝑅 − 1)/𝑅𝑅  [2] 
where RR=Risk Ratio or Hazard Ratio. 
For the premature mortality burden attributable to long-term O3 exposure, a log-linear 
exposure-response function (equation 3) is applied globally, consistent with previous global 
burden studies (Malley et al., 2017; Silva et al., 2016): 
𝑅𝑅 = 𝑒𝑥𝑝𝛽𝛥𝑋  [3] 
where 𝛽  represents the percent change in a given adverse health response (cause-specific 
premature mortality in this case) per unit increase of exposure, and 𝛥𝑋 is the change in long-
term O3 exposure relative to a threshold below which we assume there is no excess risk of 
premature mortality due to O3 exposure, because of the lack of evidence to determine the 
relationship below the threshold. We estimate cause-specific premature mortality only rather 
than all-cause mortality in order to reduce the potential bias introduced when generalizing the 
exposure-response function to populations outside of the USA, where the baseline causes of 
death may differ. In this study, we estimate chronic obstructive pulmonary disease (COPD) 
mortality only, consistent with the causes of death reported in Turner et al. (2016) and previous 
global burden studies (Cohen et al., 2017; Lim et al., 2012; GBD 2016 Risk Factor 
Collaborators, 2017; GBD 2017 Risk Factor Collaborators, 2018). For RR, we use the Hazard 
Ratio estimated from a multipollutant model adjusted for regional PM2.5, near-source PM2.5 , and 
NO2 .The increased hazard of death for COPD associated with an increment of 10 ppb change 
in 6mDM8 O3 is estimated to be 1.09 (95% CI: 1.05,1.13) (Turner et al, 2016). The threshold 
used is 32.4 ppb, which is the midpoint of the uniform distribution between the minimum and 5th 
percentile exposure experienced by the ACS CPS-II cohort, defined as ~U(29.1, 35.7) for the 
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6mDM8 exposure metric, in ppb (Turner et al, 2016). This is the same uniform distribution used 
in GBD 2017 (GBD 2017 Risk Factor Collaborators, 2018).  
For PM2.5, we use the integrated exposure-response model (IER) from GBD 2017, which 
has the following form: 
𝑓𝑜𝑟 𝑧 < 𝑧𝑐𝑓 , 𝑅𝑅𝐼𝐸𝑅(𝑧) = 1   
𝑓𝑜𝑟 𝑧 ≥ 𝑧𝑐𝑓 , 𝑅𝑅𝐼𝐸𝑅(𝑧) = 1 + 𝛼(1 − 𝑒𝑥𝑝
−𝛾(𝑧−𝑧𝑐𝑓)
𝛿
) [4] 
where 𝑧  is the annual average PM2.5, 𝑧𝑐𝑓 is the counterfactual low PM2.5 exposure concentration 
below which there is assumed to be no excess risk of death, and  𝛼 , 𝛾 and 𝛿 are parameters 
that control the overall shape of the IER curve (Burnett et al., 2014; GBD 2017 Risk Factor 
Collaborators, 2018). The IER model from GBD2017 is fit by integrating RR information from the 
literature on outdoor air pollution, household air pollution, second hand smoking and active 
smoking (GBD2017 Risk Factor Collaborators, 2018).  𝑧𝑐𝑓 is defined as 4.15 µ𝑔/𝑚
3, the 
midpoint of ~U(2.4, 5.9), in µ𝑔/𝑚3, a uniform distribution from GBD 2017 with lower and upper 
bounds corresponding to the average of the minimum and 5th percentile of ambient air pollution 
distributions experienced in cohort studies conducted in North America.  
In this study, we estimate the premature mortality burden attributable to long-term 
exposure to PM2.5 for 6 causes: chronic obstructive pulmonary disease (COPD), ischemic heart 
disease (IHD), stroke, lung cancer (LC), lower respiratory infection (LRI), and type II diabetes 
using RRs obtained from the IER. For IHD and stroke, RR values are specific for each 5-year 
segment of the age groups while for the others the RR value is applied to all ages. For each of 
these causes of death and age groups, we obtain RR values by performing a piecewise linear 
interpolation for the reported RR values for selected PM2.5 concentrations from GBD 2017.  
Population data are obtained from the Landscan 2015 Global Population Dataset by Oak 
Ridge National Laboratory at 30"x30" (Oak Ridge National Laboratory, 2016) which we re-grid 
to the resolutions of the air pollution outputs (0.125°x0.125° and 2.5°x 2°). In this study, the 
9 
 
exposed population is defined as the entire population for lower respiratory infections and adults 
aged 25 and over for the other causes of death. To estimate population per 5-year age group in 
each cell for adults aged 25 and over, we multiply the proportion of a country’s population in 
each grid cell from Landscan by the total population for the corresponding age group in that cell, 
using national records of age-distributed population from GBD 2017, assuming that the age 
distribution is uniform spatially within each nation. 
The baseline mortality rate for each cause, 𝑦0,  is calculated as the ratio of the number of 
deaths among the exposed population in a given year to the exposed population in each 
country.  The number of deaths for each cause among the exposed population is obtained for 
each of 195 countries from GBD 2017 (Global Health Data Exchange, 2017). The country-level 
number of deaths per each age group are gridded to 30"x30" and are estimated by combining 
the aforementioned proportion of a country’s population in each grid cell. The resulting baseline 
mortality per age group at 30"x30" is then re-gridded to the resolutions of the air pollution 
outputs (0.125°x0.125° and 2.5°x 2°).  
Uncertainty in mortality estimates is propagated using the lower/upper bounds of the 
95% CIs of HRs/RRs from Turner et al. (2016) and GBD 2017 (GBD 2017 Risk Factor 
Collaborators, 2018). Uncertainty from any of the other inputs (baseline mortality rates, 
population, concentrations) is not included. The lower/upper bounds of the 95% CIs of mortality 
estimates are calculated by plugging the lower/upper bounds of the 95% CIs of HRs/RRs in the 
health impact function.  Uncertainty bounds on the percent differences between different 
resolutions are found by simply subtracting values for the 95% CIs for the mortality results.  
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CHAPTER 3: RESULTS AND DISCUSSION 
3.1: PM2.5 and O3 Concentrations at Modeled Resolutions  
Figures 1 and 2 show the global spatial distribution of annual average PM2.5 
concentrations and O3 concentrations shown as the average over the consecutive 6-month 
period with the highest average of the daily 8-hr maximum (6mDM8) at the fine (0.125°x0.125°) 
and coarse (2.5°x 2°) resolutions, and differences between the coarse and fine resolutions 
(coarse - fine) respectively. PM2.5 is highest in Africa and Asia. While the direction and 
magnitude of the differences between resolutions vary spatially, PM2.5 concentrations are lower 
at the coarse resolution at most locations. Global O3 shows a smoother spatial distribution, with 
the highest concentrations in the Middle East and Asia. Although most regions witness 
decreases in O3 concentrations from the fine to the coarse resolution, the magnitude of the 
differences between resolutions is much smaller than for PM2.5, with less spatial variation.  
The maximum, mean, standard deviations, and population-weighted averages of annual 
PM2.5 and 6mDM8 O3 concentrations at both modeled resolutions and the upscaled resolution 
are shown in Table 2. For PM2.5, the mean concentrations decrease by 24.1% from the fine 
resolution to the coarse resolution. The population-weighted average, which approximates the 
average exposure experienced by the global population, decreases by 32.1% from the fine 
resolution to the coarse resolution and by 11.4% from the fine resolution to the upscaled 
resolution. The maximum value at the coarse resolution decreases by 78.5% from the fine 
resolution and at the upscaled resolution by 75.2%, showing that coarse resolutions might 
underestimate peak concentrations for PM2.5. For O3, the population-weighted average 
decreases by 46.1% from the fine resolution to the coarse resolution, and by 37.7% from the
11 
 
fine resolution to the upscaled resolution. The maximum value for the coarse resolution 
decreases by 8.9% from the fine resolution, followed by the upscaled resolution with a decrease   
of 5.4% from the fine resolution, showing that coarse resolutions also underestimate peak 
concentrations for O3 but the effect is smaller than for PM2.5. 
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(a) Fine  
(b) Coarse  
(c) Coarse - Fine 
Figure 1. Annual average total PM2.5 concentrations at the fine resolution (a), coarse resolution 
(b), and differences between the coarse and fine resolutions (PM2.5 coarse resolution – PM2.5 fine resolution) 
(c). 
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(a) Fine 
(b) Coarse 
(c) Coarse - Fine 
Figure 2. 6mDM8 O3 concentrations at the fine resolution (a), coarse resolution (b), and 
differences between the coarse and fine resolutions (O3 coarse resolution – O3 fine resolution) (c), showing 
concentrations for the consecutive 6-month period with the highest average of the daily 8-hr 
maximum O3 concentrations (6mDM8) for each grid cell.  
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Table 2. Maximum, mean, standard deviations, and population-weighted averages of annual 
PM2.5 and 6mDM8 O3 concentrations at modeled resolutions (0.125°x0.125° and 2.5°x 2°) and 
the upscaled resolution (2.5°x 2°). 
Resolution (degree) PM2.5 (µ𝑔/𝑚3) O3 (ppb) 
 max mean SD P-W 
mean 
max mean SD P-W 
mean 
Fine (0.125 x 0.125) 721.06 6.67 13.59 37.23 85.67 38.16 9.26 57.05 
Coarse (2.5 x2)  154.85 5.06 10.77 25.29 78.08 32.40 10.18 30.74 
Upscaled fine (2.5 x2) 179.14 6.73 12.95 32.98 81.03 38.18 9.25 35.55 
 
3.2: Effect of Grid Resolution on the Global Mortality Burden of PM2.5 
 Cause-specific premature mortality attributable to long-term PM2.5 exposure estimated at 
different resolutions and their percentage changes between resolutions are shown in Table 3 
and Figure 3. For the fine resolution (0.125°x0.125°), we estimated a global burden of 3.8 (95% 
CI: 2.3, 5.3) million deaths per year, with IHD and COPD contributing the most deaths 
attributable to PM2.5 exposure (Figure 3; Table 3).  
Our estimates of total PM2.5-attributable premature mortality at the fine resolution 
(0.125°x0.125°) are 29% higher than those of GBD 2017. This is accounted for by our use of 
interpolation of RR values instead of the exact IER model from GBD 2017, and differences in 
population data and in turn different spatial alignment of population, concentration and mortality 
data. Our estimates are also 17% higher than those of Apte et al. (2015), which is likely 
because we added type II diabetes as a cause and they estimated LRI deaths for children under 
five only while we estimated for all ages following GBD 2017.  
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Figure 3.  Annual mean PM2.5-attributable premature morality by cause at the fine 
(0.125°x0.125°), coarse (2.5°x 2°), and upscaled resolutions (2.5°x 2°). 
 
Table 3. Annual PM2.5-attributable mortality (95% CI) by cause at the fine (0.125°x0.125°), 
coarse (2.5°x 2°), and upscaled resolutions (2.5°x 2°). 
Cause-specific 
mortality 
Mortality (thousands) Percentage change (%) 
Fine  Coarse Upscaled Fine to 
Coarse 
Fine to 
upscaled 
Chronic obstructive 
pulmonary disease 
830  
(504,1107) 
692  
(393,961) 
786 
(467, 1062) 
-16.7 
(-22.0, -13.2) 
-5.3 
(-7.3, -4.0) 
Type II Diabetes 267  
(159, 334) 
228  
(129,302) 
257 
(150, 329) 
-14.5 
(-19.3, -9.6) 
-3.6 
(-5.7, -1.5) 
Ischemic heart 
disease 
1199  
(730, 1712) 
1049  
(607,1546) 
1144 
(683, 1656) 
-12.5 
(-16.8, -9.7) 
-4.5 
(-6.4, -3.3) 
Lung cancer 307  
(213, 407) 
246  
(164,337) 
281  
(191, 377) 
-19.7 
(-23.0, -17.1) 
-8.6 
(-10.2, -7.2) 
Lower respiratory 
infections 
605  
(450, 774) 
464 
(326, 628) 
565  
(415, 735) 
-23.4 
(-27.5, -18.9) 
-6.6 
(-7.7, -5.1) 
Stroke 594  
(217, 989) 
521 
(174,902) 
568  
(200, 961) 
-12.3 
(-19.6, -8.8) 
-4.3 
(-7.5, -2.8) 
Total of six causes  3801 
(2273, 5323) 
3200  
(1793, 4677) 
3602  
(2107, 5121) 
-15.8 
(-21.1, -12.1) 
-5.2 
(-7.3, -3.8) 
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(a) Fine  
(b) Coarse 
(c) Coarse – Fine 
Figure 4. Annual mean of total PM2.5-attributable premature mortality [chronic obstructive 
pulmonary disease (COPD)+ ischemic heart disease (IHD)+lower respiratory infections 
(LRI)+lung cancer (LC) +stroke + type II diabetes] at the fine resolution (a), coarse resolution 
(b), and differences in mortality between coarse and fine resolutions (PM2.5-attributable mortality 
coarse resolution – PM2.5-attributable mortality fine resolution) (c). (a) and (b) are plotted with a log scale.  
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 Table 4. Annual PM2.5-attributable mortality total (95% CI) by world region at the fine 
(0.125°x0.125°), coarse (2.5°x 2°), and upscaled resolutions (2.5°x 2°).  World regions are 
defined in the Supporting Information. 
 
The coarse resolution underestimates global total PM2.5-attributable premature mortality 
by -15.8% (-21.1%, -12.1%) compared to the fine resolution (Table 3). Upscaling grid resolution 
by simple averaging of PM2.5 concentrations from the fine resolution to the coarse resolution 
underestimates mortality by -5.2% (-7.3%, -3.8%), which accounts for the bias due to the limited 
ability of the coarse resolution to capture population and concentration gradients. This indicates 
that the bias at coarse resolution from model “chemistry” [-10.6% (-13.8%, -8.3%)] accounts for 
about 67% of the total bias and is the main contributor to the total negative bias on PM2.5-
attributable premature mortality burden globally compared to “exposure”.  
World regions Mortality (thousands) Percentage change (%) 
Fine  Coarse Upscaled Fine to 
Coarse 
Fine to 
upscaled 
East Asia 1184  
(726, 1613) 
1068  
(627, 1495) 
1133  
(681, 1563) 
-9.8 
(-13.6, -7.3) 
-4.3 
(-6.2, -3.1) 
Southeast Asia 
286  
(162, 409) 
200  
(97, 319) 
264  
(144, 389) 
-30.0 
(-40.4, -22.1) 
-7.7 
(-11.4, -5.1) 
South Asia 
1118  
(716, 1482) 
920  
(542, 1285) 
1074  
(677, 1436) 
-17.7 
(-24.3, -13.3) 
-4.0 
(-5.4, -3.1) 
Oceania 7.8 
(3.0, 14.1) 
5  
(2, 10) 
7.8 
(2.9, 14.4) 
-30.7 
(-28.0, -32.1) 
0.6 
(-3.6, 2.5) 
Russia and Central 
Asia 
117  
(55,191) 
116  
(54,190) 
108  
(48, 182) 
-0.83 
(-1.1, -0.78) 
-7.4 
(-12.5, -4.6) 
Europe 271  
(124, 451) 
294  
(143, 472) 
247  
(106, 426) 
8.5 
(4.5, 15.6)  
-8.8 
(-14.5, -5.7) 
Middle East and North 
Africa 
127  
(69, 188) 
129  
(71, 190) 
125  
(68, 187) 
2.0 
(1.2, 3.1) 
-1.1 
(-1.6, -0.9) 
Sub-Saharan Africa 355  
(241, 466) 
292  
(188, 401) 
347  
(234, 457) 
-17.7 
(-21.8, -13.8) 
-2.3 
(-2.8, -1.9) 
North America 165  
(91, 243) 
77  
(30, 141) 
151  
(81, 228) 
-53.1 
(-67.4, -42.0) 
-8.4 
(-11.6, -6.1) 
Latin America and the 
Caribbean 
170  
(86, 265) 
97  
(39, 174) 
144  
(66, 239) 
-42.7 
(-54.6, -34.2) 
-15.2 
(-23.7, -9.7) 
Global 3801  
(2273,5323) 
3200  
(1793, 4677) 
3602  
(2107, 5121) 
-15.8 
(-21.1, -12.1) 
-5.2 
(-7.3, -3.8) 
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As shown in Figure 3 and Table 3, lower respiratory infections (LRI) is most affected by 
the decrease of grid resolution from fine to coarse [-23.4% (-27.5%, -18.9%)], followed by lung 
cancer [-19.7% (-23.0%, -17.1%)]. 
The global spatial distribution of the annual mean of total PM2.5-attributable premature 
mortality at the fine (0.125°x0.125°) and coarse (2.5°x 2°) resolutions, and differences between 
the coarse and fine resolutions (coarse - fine) are shown in Figure 4. The direction and 
magnitude of the mortality differences between resolutions vary substantially among regions 
(Figure 4; Table 4). The highest mortality occurs in East Asia (31%), followed by South Asia 
(29%) and Sub-Saharan Africa (9%). The greatest percentage change of mortality estimates 
from the fine resolution to the coarse resolution is seen in North America, followed by Latin 
America and the Caribbean, Oceania, and Southeast Asia. This shows that the dilution of peak 
and population-weighted PM2.5 concentrations and failure to align peak concentrations and 
population at the coarse resolution are the most pronounced in these regions. Europe and the 
Middle East and North Africa are the only two regions where the coarse resolution 
overestimates PM2.5-attributable premature mortality, corresponding to regions where increases 
in PM2.5 are seen in Figure 1 (c). The greatest “exposure” effect caused by coarse resolution is 
seen in Latin America and the Caribbean, followed by Europe and North America, indicating 
where the failure of the coarse resolution to capture population and concentration peaks is the 
most significant. Russia and Central Asia is the only region among the ten world regions where 
the “exposure” effect appears to be the main contributor to the total bias on PM2.5-attributable 
premature mortality burden.  
We found a larger total negative bias for PM2.5-attributable premature mortality both 
globally [-15.8% (-21.1%, -12.1%)] and for North America [-53.1% (-67.4%, -42.0%)] at the 
coarse resolution (2.5°x 2°) compared to the fine resolution (0.125°x0.125°) than Li et al. (2016), 
who estimated a total bias of -8% at the coarse resolution (2×2.5°) compared to the fine 
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resolution (0.5×0.66°) for the USA. Our estimated “exposure” effect for the global domain [-5.2% 
(-7.3%, -3.8%)] is slightly smaller compared to their estimates for the USA (- 7%) and our 
estimated “exposure” effect for North America [-8.4% (-11.6, -6.1)] is closer to theirs. We found 
a larger “chemistry” effect both globally [-10.6% (-13.8%, -8.3%)] and for North America [-44.7% 
(-55.8%, -35.9%)] than theirs (-1%).The other difference is that the effect of resolution on 
“chemistry” is found to be the main contributor to the overall bias at coarse resolution in our 
study (67%) whereas the effect on “exposure” appears to account for most of the bias in Li et al. 
(2016) (88%). Our results for the “exposure” effect both globally and for North America are in 
the same direction but smaller compared to those of Punger and West (2013), who found that 
mortality estimates at >250 km resolution are 30 – 40 % lower than the 12-km estimates for the 
USA due to the “exposure” effect only. Korhonen et al. (2019) found a much larger negative 
“exposure” effect on PM2.5-attributable premature mortality (-90%) for Finland at 50km 
compared to 1km. 
 
3.3: Effect of Grid Resolution on the Global Mortality Burden of O3 
We estimate a global burden of 0.68 (95% CI: 0.41, 0.92) million premature COPD 
deaths attributable to long-term O3 exposure for the fine resolution (0.125°x0.125°). Our 
estimate for O3-attributable premature COPD mortality is higher than GBD2017 [0.47 (95% CI: 
0.18, 0.77) million] by 45%, likely due to different HR values used from those in GBD 2017 [1.06 
(95% CI: 1.02,1.10)] and different threshold values. Our estimates are lower than Malley et al. 
(2017) by 34% when compared to their results using the low-concentration cutoff, and 45% 
using their high-concentration cutoff, which is mainly because they estimated all respiratory 
mortality rather than COPD mortality and they used annual average 8-hr daily max O3 as the 
exposure metric while we used 6mDM8. 
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Figure 5 shows the global spatial distribution of the annual mean of O3-attributable 
premature COPD mortality at the fine (0.125°x0.125°) and coarse (2.5°x 2°) resolutions, and 
differences between the coarse and fine resolutions (coarse - fine). The magnitude of the 
differences between O3-attributable mortality using coarse and fine resolutions (Figure 5; Table 
5) has less spatial variation than for PM2.5. The coarse resolution underestimates global O3-
attributable COPD premature mortality by -9.0% (-9.4%, -8.6%) compared to the fine resolution. 
Increasing grid resolution by simple averaging of O3 concentrations has little effect on the 
estimated COPD mortality, with a change of - 0.12% (-0.16%, -0.09%), which shows that bias at 
coarse resolution from the “ exposure” effect is negligible and that model “chemistry” [-8.8% (-
9.2%, -8.5%)] is also the main contributor to the total bias on O3 -attributable premature mortality 
burden globally, accounting for about 98% of the total bias. The majority of mortality occurs in 
South Asia (44%) followed by East Asia (36%), and Europe (7%). The greatest percentage 
change of mortality estimates from the fine resolution to the coarse resolution is seen in North 
America, followed by Southeast Asia, and Latin America and the Caribbean. Those are also 
regions where differences of PM2.5-attributable premature mortality between the fine vs. coarse 
resolution are the biggest. Oceania is the only region where the coarse resolution overestimates 
O3-attributable premature mortality but one of the regions where underestimation of PM2.5-
attributable premature mortality is greatest. The greatest “exposure” effect caused by coarse 
resolution is seen in Russia and Central Asia, followed by Southeast Asia. Bias at coarse 
resolution from model chemistry is the main contributor to the total bias on O3-attributable 
premature mortality burden in all ten world regions. O3 shows less bias at coarse resolution than 
PM2.5 does, because the lifetimes of O3 and its precursors are longer than for PM2.5 and its 
precursors, resulting in O3 concentrations that are smoother spatially. 
Contrary to the less than 6% positive bias that Punger and West (2013) found at 
resolutions larger than approximately 96 km, we found a small negative bias [-9.0% (-9.4%, -
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8.6%)] at the coarse resolution (~276x 221 km2 at the equator, with decreasing grid sizes when 
moving towards the poles) for O3-attributable premature mortality. However, Punger and West 
(2013) studied the USA only and evaluated the bias due to exposure only, while we studied the 
global domain and the total effect due to both chemistry and exposure. Our results for the 
“exposure” effect for North America are consistent with theirs, with a minor positive bias of 
1.59% (1.56%, 1.63%). 
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(a) Fine 
(b) Coarse 
c) Coarse- Fine 
Figure 5. Annual mean of O3-attributable premature chronic obstructive pulmonary disease 
(COPD) mortality at the fine resolution (a), coarse resolution (b), and differences of mortality 
between coarse and fine resolutions (O3-attributable mortality coarse resolution – O3-attributable 
mortality fine resolution) (c). (a) and (b) are plotted with a log scale.  
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Table 5. Annual O3-attributable chronic obstructive pulmonary (COPD) mortality (95% CI) by 
world region at the fine (0.125°x0.125°), coarse (2.5°x 2°), and upscaled resolutions (2.5°x 2°). 
 
 
 
 
World regions 
Mortality (thousands) Percentage change (%) 
Fine  Coarse Upscaled 
Fine to 
Coarse 
Fine to 
upscaled 
East Asia 
245  
(147, 329) 
235 
(141, 317) 
252 
(152, 339) 
 -3.8 
(-4.1, -3.6) 
3.2 
(3.1, 3.3) 
Southeast Asia 
24 
(14, 33) 
19 
(11, 26) 
21 
(13, 29) 
 -22.8 
( -23.4, -22.3) 
 -11.2 
(-11.6, -10.9) 
South Asia 
298 
(181, 397) 
270 
(162, 361) 
292 
(177, 389) 
 -9.6 
(-10.2, -9.1) 
 -2.0 
(-2.1, -1.9) 
Oceania 
0.35 
(0.20, 0.49) 
0.38 
(0.22, 0.53) 
0.34 
(0.20, 0.48) 
 8.8 
(8.3, 9.3) 
-1.9 
(-2.2, -1.7) 
Russia and Central 
Asia 
4.8 
(2.8, 6.6) 
4.7 
(2.7, 6.5) 
5.5 
(3.2, 7.6) 
-1.8 
( -2.1, -1.6) 
15.36 
(15.34, 15.38) 
Europe 
46 
(27, 62) 
41 
(24, 56) 
45 
(26, 61) 
 -10.9 
(-11.2, -10.7) 
-1.34 
(-1.38, -1.31) 
Middle East and North 
Africa 
9.1 
(5.4, 12.4) 
8.5 
(5.0, 11.6) 
9.6 
(5.7, 13.0) 
-7.0 
(-7.4, -6.6) 
5.6 
(5.5, 5.7) 
Sub-Saharan Africa 
12.5 
(7.3, 17.1) 
11.6 
(6.8, 15.9) 
12.1 
(7.1, 16.6) 
-7.1 
(-7.1, -7.1) 
 -3.2 
(-3.3, -3.1) 
North America 
31 
(18, 42) 
22 
(13, 30) 
31 
(19, 43) 
-28.6 
(-29.4, -27.8) 
1.59 
(1.56, 1.63) 
Latin America and the 
Caribbean 
14.0 
(8.2, 19.3) 
11.4 
(6.6, 15.7) 
13.4 
(7.8, 18.5) 
-18.7 
(-18.8, -18.5) 
-4.05 
(-4.14, -3.97) 
Global  
684 
(411, 919) 
623 
(372, 840) 
683 
(410, 918) 
-9.0 
(-9.4, -8.6) 
 -0.12 
(-0.16, -0.09) 
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CHAPTER 4: CONCLUSIONS 
Using a fine resolution model simulation (0.125°x0.125°), we estimated a global burden 
of 3.8 (95% CI: 2.3, 5.3) million deaths per year for long-term PM2.5 exposure and a global 
burden of 0.68 (95% CI: 0.41, 0.92) million premature COPD deaths attributable to long-term O3 
exposure. IHD and COPD account for the most PM2.5 -attributable premature mortality.  
 We compared global premature mortality attributable to PM2.5 and O3 using 
concentrations simulated at the fine (0.125°x0.125°) and coarse (2.5°x 2°) resolutions to study 
the biases in health effects when using coarse resolution models. We also evaluated the effect 
on “exposure” only by comparing mortality estimates at the fine resolution and the upscaled 
resolution (2.5°x 2°).  To our best knowledge, this is the first study to investigate the effect of 
grid resolution on premature mortality from exposure to both PM2.5 and O3 on the global scale, 
and whether the biases from coarse resolution differ among world regions.  
The coarse resolution underestimates the premature mortality burden for both PM2.5 [-
15.8% (-21.1%, -12.1%)] and O3 [-9.0% (-9.4%, -8.6%)]. Upscaling the fine resolution to coarse 
resolution reduces the estimated premature mortality burden for PM2.5 [-5.2% (-7.3%, -3.8%)] 
but hardly changes that for O3 [-0.12% (-0.16%, -0.09%)]. Therefore the effect of grid resolution 
on “chemistry” is the main contributor to the overall bias at coarse resolution for both PM2.5 
(accounts for 67% of the total bias) and O3 (98% of the total bias). The smaller coarse resolution 
bias for O3 can be explained by the longer lifetime and more uniform spatial distribution of O3 
compared to PM2.5 and hence less misalignment of gradients in population and concentration 
data. Among all the causes, PM2.5 -attributable premature mortality associated with lower 
respiratory infections (LRI) and lung cancer (LC) are the most sensitive to grid resolution.
25 
 
In addition, we find for the first time that the bias due to resolution varies substantially 
among world regions. For PM2.5, the effect of grid resolution is most significant in North America, 
followed by Latin America and the Caribbean, Oceania, and Southeast Asia. For O3, it is largest 
in North America, followed by Southeast Asia, and Latin America and the Caribbean. While it is 
not immediately clear why some regions have greater bias than others, it is interesting that the 
estimated bias is greatest in the Americas.  These differences likely result from differences in 
several factors including emission source sectors and levels, meteorology, and the spatial 
distributions of population, emissions, and land use.   
Our results are consistent with previous studies at national to global scales that are 
conducted at comparable resolutions, finding that coarse resolutions underestimate PM2.5-
attributable premature mortality (Punger and West, 2013; Li et al., 2016; Fenech et al., 2018; 
Korhonen et al., 2019). The magnitudes of the bias are larger than those from Li et al. (2016) 
and Fenech et al. (2018) and smaller than those from Punger and West (2013) and Korhonen et 
al. (2019). Although we found a negative bias for O3-attributable premature mortality as opposed 
to the positive bias found by Punger and West (2013), our results on the “exposure” effect for 
North America are consistent with theirs for the USA. Different results on the bias of coarse 
resolution given by different studies may result from the variation in the domains of the 
atmospheric models, differences in the models themselves, the range of grid resolutions 
considered, and the causes of death and exposure-response functions used. 
Several limitations of this study may lead to uncertainties in the mortality estimates and 
the effect of grid resolution. Since we only included adult population in the estimates for all the 
causes except LRI due to limitations in epidemiological evidence, the total global mortality 
burden of air pollution might be underestimated. The use of threshold values for both PM2.5 and 
O3 mortality due to lack of epidemiological evidence to determine the relationship below the 
threshold can bring uncertainties in both the mortality estimates and the effect of grid resolution. 
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In addition, we performed a linear interpolation for the relative risk values obtained from the IER 
model from GBD 2017 instead of using the model itself, which also introduces uncertainties to 
both the mortality estimates and the effect of grid resolution.   
As coarse global models are necessary for some applications such as simulations of the 
effects of changes in emissions and of future emissions and global climate change scenarios, 
we recommend acknowledging that health impacts for O3 and especially PM2.5 estimated with 
global models at coarse resolutions are likely underestimates and should be interpreted with 
caution. Future research should examine the effect of grid resolution for different primary and 
secondary species of PM2.5, which is not considered in this study. In addition, it’s also 
worthwhile to evaluate the effect on health impacts associated with experiments where 
emissions are changed, such as evaluating the contributions of different emission source 
sectors and effects of different policies globally.  
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APPENDIX 
    
Figure 6. Ten world regions 
 
Figure 7. Spatial distribution of exposed population (of 25 and over) at the fine resolution 
(0.125°x0.125°) 
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